12-02-2014
Le secteur de la santé devrait profiter des nouveautés du portefeuille de matières plastiques SABIC qui seront dévoilées à Pharmapack 2014
SITTARD, Pays-Bas, 12 février 2014 - En participant à Pharmapack Europe 2014 (à Paris, les 12 et 13 février), SABIC entend manifester son intention de poursuivre son avancée sur le secteur de la santé. Sur le stand 354, SABIC présentera deux nouveaux grades pharmaceutiques de polypropylène, destinés aux seringues, à d’autres dispositifs de dosage médicaux et à des applications d’emballage des produits de soins. Ces deux grades, à savoir le SABIC® PP PCGR40 et sa version lubrifiée SABIC® PP PCGR40L, sont des copolymères statistiques à haute fluidité qui sont couramment utilisés pour fabriquer des produits à faibles épaisseurs de paroi et dotés d’une transparence très élevé.
12-02-2014
Clariant Healthcare Packaging promotes growing capacities and product offerings at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, represented by its business line Healthcare Packaging, will exhibit its expanding portfolio of protective packaging for pharmaceuticals at Pharmapack Europe 2014 Paris. A long time leader in pharmaceutical desiccants, oxygen scavengers and specialized container closure systems, Clariant Healthcare Packaging, along with Clariant Medical Masterbatches, will once again present its solutions to customers at PharmaPack.
12-02-2014
Clariant Healthcare Packaging Collaborates with Pumpart for Airless Technologies for Protecting Pharmaceutical Creams
Muttenz, February 12, 2014 - Clariant, a world leader in specialty chemicals, through its Healthcare Packaging business segment, has announced a partnership and collaboration with PumpArt System® for the introduction of an innovative airless dispensing technology, Tubairless®, to the pharmaceutical industry.
12-02-2014
Clariant supports the ocular medicine packaging with launch of new global and compliant standard color range of masterbatches for caps and closures at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, In the Healthcare sector, coloration of plastics plays an important role in protecting patients by identifying drug types or doses, thereby reducing the risk of errors. However, these plastic packaging materials and the colorants in them need assessment of how they behave in contact with the drug during storage and use. These extractable and leachable studies on the packaging material, play an important role in medium and high risk applications such as ocular medicines, but if something changes in the polymers or masterbatches used to manufacture the packaging, then the data from the extractable and leachable studies may no longer be valid. To address these issues Clariant has used in dedicated expertise to create a new range of standard masterbatch colors, offering the benefits of the MEVOPUR® brand, tailored to the color standard developed by the American Society of Ophthalmology.
12-02-2014
Clariant opens the door for productivity and sustainability in pharmaceutical packaging with European Pharmacopeia tested additives
Muttenz, February 12, 2014 – Clariant, one of the world leaders in specialty chemicals, supports the Healthcare industry with a range of products developed for medical devices and pharmaceutical plastic packaging. With its knowledge, Clariant’s MEVOPUR® nucleant product brings improvements in the process of plastic packaging fabrication. Thanks to them the processing time can be reduced; mechanical properties improved and so companies can save time and increase the productivity. The nucleating agents used in MEVOPUR products are pre-tested using extraction protocols such as those established by US Pharmacopeia, ISO and NEW European Pharmacopeia monograph 3.1.3; the goal is helping companies to meet the challenging regulatory requirements to support “Controlled, Consistent and Compliant”.
12-02-2014
Clariant launches new ‘EP’ masterbatch range for pharmaceutical packaging at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, Since the launch of the MEVOPUR® range of masterbatch and compounds for Healthcare applications at the end of 2010, Clariant has been active in bring new ideas and products to the market, with the objective of ‘Enhancing Products and Process’ and ‘Protecting the Patient and the Drug’. In particular in the last 12 months, new additive masterbatches have attracted high interest because Clariant had pre-tested the raw materials for the masterbatches using the extraction and biological evaluation protocols of US Pharmacopeia (USP) 23 parts 87 and 88. However initial feed-back raised the question of whether the substances were also listed European Pharmacopeia chapter 3.1.3 (EP 3.1.3). Clariant has reacted to this feed-back and recently completed a test programme on raw materials of its masterbatches, and is now offering products that use raw materials that have been pre-evaluated to both the above USP and EP standards.
12-02-2014
Clariant un-taps creativity potential for the healthcare sector at Pharmapack Europe 2014 Paris
Muttenz, February 12, 2014 – Clariant, a world leader in specialty chemicals, continues to demonstrate that it is possible to combine creativity with enhanced protection and processing performance for healthcare applications with its sector-dedicated MEVOPUR® polymer and packaging solutions at Pharmapack Europe 2014 Paris (booth 330). MEVOPUR color and performance additives are developed and produced at three ISO 13485 certified and dedicated production facilities located in USA, Europe and Asia to ensure ‘Controlled, Consistent and Compliant’ innovations for the industry.
12-02-2014
Clariant continue d’investir dans l’innovation des nouveaux produits à Pharmapack Europe 2014 Paris
Muttenz, 12 février 2014 – Clariant, l’un des leaders mondiaux dans les produits chimiques, démontre sa capacité à combiner la créativité tout en améliorant la capacité et la performance dans l’utilisation des traitements pharmaceutiques grâce à son secteur-dédié, MEVOPUR® polymer and packaging solutions qui sera représenté à Pharmapack Europe 2013 Paris. Les couleurs et additifs performants MEVOPUR sont développés et fabriqués dans le cadre de la certification ‘ISO 13485’ sur 3 sites : aux Etats-Unis, en Europe et en Asie afin de promouvoir des innovations ‘Controlled, Consistent and Compliant’ pour ce secteur.
